GlassScriptPhysician profile
Kindal M Burleson
NPI 1740736008
$9,084.31
in general payments reported to CMS, 2019-2025
49 companies · $892 in 2025
The $892 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,550 · 2022: $2,022 · 2023: $2,970 · 2024: $1,650 · 2025: $892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,512.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,459.51 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,028.36 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $633.15 | 2021-2025 | |
| Amgen INC. | $467.85 | 2021-2025 | Evenity, Prolia, Repatha |
| Novartis Pharmaceuticals Corporation | $428.62 | 2021-2025 | |
| Novo Nordisk INC | $385.51 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Shionogi INC | $352.66 | 2021-2024 | Fetroja |
| Glaxosmithkline, LLC. | $348.49 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $347.80 | 2021-2024 | Zerbaxa, Dificid, Recarbrio |
| Esperion Therapeutics, INC. | $313.21 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.54 | 2021-2025 | Jardiance |
| Gilead Sciences, INC. | $291.30 | 2021-2024 | |
| Dexcom, INC. | $278.53 | 2022-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Bayer Healthcare Pharmaceuticals INC. | $200.36 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $200.28 | 2021 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $171.67 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.84 | 2021-2023 | Xifaxan |
| Abbott Laboratories | $164.96 | 2022-2025 | Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $143.93 | 2022 | |
| Melinta Therapeutics, LLC | $135.53 | 2022-2024 | Kimyrsa, Vabomere, Rezzayo |
| Lilly USA, LLC | $124.05 | 2021-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $117.04 | 2021-2023 | |
| Corcept Therapeutics | $102.36 | 2024-2025 | Korlym |
| Astellas Pharma US INC | $80.91 | 2023-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $76.99 | 2021-2022 | |
| Daiichi Sankyo INC. | $68.62 | 2022-2024 | Injectafer |
| Phathom Pharmaceuticals, INC. | $63.64 | 2024-2025 | Voquezna |
| Viiv Healthcare Company | $62.61 | 2023-2024 | Rukobia |
| Medtronic, INC. | $62.37 | 2024 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $56.28 | 2023-2025 | Spravato, Xarelto |
| Exact Sciences Corporation | $54.54 | 2023 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $40.54 | 2023-2024 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $39.54 | 2021-2023 | Gvoke Hypopen |
| Acadia Pharmaceuticals INC | $29.33 | 2021 | |
| Antares Pharma, INC. | $28.79 | 2024-2025 | Xyosted |
| Eisai INC. | $27.00 | 2021 | |
| Pharmacosmos Therapeutics INC. | $25.85 | 2021 | |
| Recor Medical INC | $25.84 | 2024 | Paradise Renal Denervation System |
| Ultragenyx Pharmaceutical INC. | $24.20 | 2021 | |
| Halozyme INC | $22.04 | 2023 | |
| Inari Medical, INC. | $21.80 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Tandem Diabetes Care, INC. | $17.33 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Otsuka America Pharmaceutical, INC. | $16.00 | 2023 | Rexulti |
| Idorsia Pharmaceuticals US INC | $15.74 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $15.68 | 2025 | Symbravo |
| Supernus Pharmaceuticals, INC. | $14.30 | 2023 | Xyosted, Qelbree |
| Dynavax Technologies Corporation | $14.17 | 2024 | Heplisav-B |
| Vyera Pharmaceuticals, LLC | $11.61 | 2021 | |
| Organon LLC | $7.04 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kindal Burleson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.